The incretin hormones have indeed a great potential for the treatment of diabetes, but the extremely short biological half-life of these peptides, due to efficient enzymatic degradation by Dipeptidyl Peptidase (DPP)-4 and subsequent renal filtration, severely limits therapeutic applicability [43]. Here, GCG is linked to diabetes mellitus.